Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Inst Nationwide Childrens HospitalfiledCriticalRes Inst Nationwide Childrens Hospital
Priority claimed from PCT/US2016/061703external-prioritypatent/WO2017083776A1/fr
Publication of MA42736A1publicationCriticalpatent/MA42736A1/fr
Publication of MA42736B1publicationCriticalpatent/MA42736B1/fr
Medicines Containing Material From Animals Or Micro-Organisms
(AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
L'invention concerne des vecteurs aav exprimant le gène ano5 et une thérapie antioxydante qui sont utilisés en tant que méthodes d'induction de la régénération musculaire et une méthode de traitement de la dystrophie musculaire.
MA42736A2015-11-122016-11-11Méthodes de traitement de la dystrophie musculaire
MA42736B1
(fr)